Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
BPI US West: Digital Manufacturing Takes Hold in Bioprocessing
Bioprocessing International (BPI) US West 2021 kicked off its virtual edition this morning, Monday March 29. An annual event, BPI West encompasses presentation, posters and networking events focused on the latest developments in bioprocessing and cell and gene therapy. A talk this morning, “Integration of Paperless Benchtop Instruments in Clinical Manufacturing,” presented by Simon Barskyi […]
The State of the Scientific Instruments Market After the COVID-19 Pandemic
In 2020, the laboratory analytical and life science instrumentation industry played a critical role in assisting various end-markets in abating the COVID-19 pandemic. Select vendors were able to weather business disruptions by meeting pandemic-related demand for certain product offerings. However, the question now is, what will be the condition of the laboratory analytical and life […]
BioProcess International US West to Present Latest Developments in Bioprocessing
The annual BioProcess International US West Conference & Exhibition will be held March 29–30 virtually. The conference consists of six tracks: Cell Line Development & Engineering; Cell Culture; Recovery & Purification; Manufacturing Strategy & Bioprocessing 4.0; Intensified & Continuous Processing; Cell & Gene Therapies; and the 4th Annual BioInnovation Group Technology Session. BioProcess International US […]
The Molecular Point-of-Care Market Expected to Have a Bumpy Ride
The advent of the COVID-19 pandemic in 2020 has made the need for molecular point-of-care (mPOC) technologies, such as testing for strep throat, HPV, tuberculosis and more, have further driven demand from the clinical and medical sectors. As a result, more companies are offering related products to fulfill end-user demand. In January 2021, Kalorama Information […]
Danaher’s SCIEX and Molecular Devices Businesses Debut New Products
It has been a busy beginning of the year for Danaher’s Life Sciences segment. In January, the business reported 2020 revenues of $10.6 billion, representing 47% of the total revenues of science and technology conglomerate Danaher. The Life Sciences unit such as biopharmaceuticals and COVID-19 vaccines. In 2020, the pharmaceutical end-market represented approximately 25% of […]